Monthly Archives - December 2020

Cyclopharm (ASX:CYC) on pathway to US sales

11 Dec 2020 - Cyclopharm Limited (ASX:CYC) CEO & Managing Director James McBrayer talks about USFDA approval for Technegas, the company's USA commercialisation plan, and opportunities beyond its key diagnostic market for pulmonary embolism.

Read more...

CSL (ASX:CSL) halts Aussie vaccine after false HIV positives: Aus shares to open lower

11 Dec 2020 - Aussie shares are set for a dip at the open following a lacklustre finish on Wall Street. Shares in vacation rental online marketplace Airbnb more than doubled after listening on the Nasdaq last night. Meanwhile, iron ore continues to improve. CSL’s (ASX:CSL) Phase 1 Covid vaccine trial with the University of Queensland will not progress to Phase 2 after the drug caused participants to have “false positive” readings for HIV.

Read more...